Diabetes mellitus Samples

Central BioHub offers human serum samples from patients with Diabetes mellitus like Type 2 diabetes mellitus or Unspecified diabetes mellitus. You can use the filter functions to specify your desired products by laboratory parameters and donor specifications like ethnicity, BMI, medication, age and gender. Procurement takes place from consented donors under strict ethical standards. For normal control groups please switch to the category Healthy Donors. If you do not find the research samples you are looking for, please contact us.

Available filters
-
-
602 Products

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0

Donor:
Gender: Male Age: 43
Diagnosed disease:
E10.01 - Type 1 diabetes mellitus with ketoacidosis
Medication:
Kreon
Parameter:
Anti-Glutamate Decarboxylase (GAD) Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyroglobulin (Tg) Thyrotropin (TSH) Thyroxine (FT4) Triglycerides Triiodothyronine (FT3)
Donor:
Gender:
Male
Age:
43 Years
BMI:
36 kg/m²
Weight:
121 kg
Height:
183 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • Type 1 diabetes mellitus with ketoacidosis [E10.01]
Medication:
  • Kreon
  • Lantus
  • Novorapid
  • amlodipine
  • atorvastatin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Glutamate Decarboxylase (GAD)
Qual: negative
Quant: < 0.60 U/mL
Source: this donation
< 0.90 U/mL
Method: RIA (Radioimmunoassay)
System: LKB 147 Gamma Counter Berthold Technologies
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: < 50.00 IU/mL
Source: this donation
< 100 IU/mL
Method: EIA (Enzyme Immuno Assay)
System: not specified not specified
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 39.90 kU/L
Source: this donation
< 35.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 77.00 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 0.80 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroglobulin (Tg)
Qual: negative
Quant: 3.01 ng/mL
Source: this donation
2.00 - 70.00 ng/mL
Method: LIA (Luminescence Immuno Assay)
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.57 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 13.60 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triglycerides
Qual: negative
Quant: 1.02 mmol/L
Source: this donation
< 2.25 mmol/L
Method: not specified
System: not specified Beckman Coulter
Triiodothyronine (FT3)
Qual:
Quant: 4.00 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH180212
183 mL (€6,862.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Sodium heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
Sodium heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147121
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147118
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Euthyrox
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
74.5 kg
Height:
168 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • Thyrotoxicosis with diffuse goitre [E05.0]
  • E11.90
  • hypertension
  • hypoparathyroidism - partial (not specified)
Medication:
  • Euthyrox (Dosages: 112µg)
  • Lantus (active agent: insulin glargin)
  • Metoprolol
  • Novorapid (active agent: insulin aspart)
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 16.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
TSH Receptor Antibodies (TRAb)
Qual:
Quant: 24.27 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 0.73 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 18.40 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 2.30 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH147115
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 63 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
63 Years
Ethnic group:
European/Caucasian
BMI:
56 kg/m²
Weight:
152 kg
Height:
165 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • hypertension
  • sleep apnoea
Medication:
  • insulin
  • metformin
Therapy:
  • cardiac valve replacement
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH146089
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E11.90

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Humalog
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
70 kg
Height:
164 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • E11.90
Medication:
  • Humalog (active agent: insulin lispro)
  • Lantus (active agent: insulin glargin)
  • Metex (Dosages: 20mg/week)
  • Orencia (Dosages: 750mg/4 weeks, active agent: abatacept)
  • Prednisolon (Dosages: 1mg, as needed)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: 33.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 4.71 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.10 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 35.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total IgM
Qual: positive
Quant: 32.00 mg/dl
Source: this donation
40.00 - 230.00 mg/dl
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295179
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 68 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
DPP-4 inhibitor
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
68 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
98 kg
Height:
180 cm
Sample:
Matrix:
Serum
Condition:
not specified
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • thyroid disease
Medication:
  • DPP-4 inhibitor
  • blood thinner (because of stroke)
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 3.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH282850
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E06.3

Donor:
Gender: Female Age: 33 Ethnic group: European/Caucasian
Diagnosed disease:
E10.01 - Type 1 diabetes mellitus with ketoacidosis
Medication:
L-thyroxine
Parameter:
Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Female
Age:
33 Years
Ethnic group:
European/Caucasian
BMI:
22 kg/m²
Weight:
63 kg
Height:
168 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • Type 1 diabetes mellitus with ketoacidosis [E10.01]
Medication:
  • L-thyroxine (Dosages: 100not specified)
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroid peroxidase (aTPO / MAK)
Qual: positive
Quant: 319.40 kIU/L
Source: previous donation
< 34.00 kIU/L
Method: not specified
System: Cobas Modular Roche
TSH Receptor Antibodies (TRAb)
Qual: negative
Quant: 0.62 IU/L
Source: previous donation
< 1.22 IU/L
Method: not specified
System: Cobas Modular Roche
Thyrotropin (TSH)
Qual: positive
Quant: 23.37 mIU/L
Source: previous donation
0.27 - 4.20 mIU/L
Method: not specified
System: not specified Roche
Thyrotropin (TSH)
Qual: positive
Quant: 5.010 mU/L
Source: this donation
Remarks: sensitive
0.270 - 4.200 mU/L
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 e-Module Roche
Thyroxine (FT4)
Qual: negative
Quant: 12.70 pg/mL
Source: previous donation
9.30 - 17.00 pg/mL
Method: not specified
System: not specified Roche
Triiodothyronine (FT3)
Qual: negative
Quant: 2.60 pg/mL
Source: previous donation
2.00 - 4.40 pg/mL
Method: not specified
System: not specified Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292329
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
L-thyroxine
Parameter:
Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
41 kg/m²
Weight:
112 kg
Height:
165 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • thyroid disease
Medication:
  • L-thyroxine
  • Toujeo (specific information from donor: Toujeo 300 U/ml)
  • atorvastatin
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Blood sugar (fasting)
Qual:
Quant: 135.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.60 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165497
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Anti-Thyroglobulin (aTg / TAK), Anti-... - E06.3

Donor:
Gender: Male Age: 18 Ethnic group: European/Caucasian
Diagnosed disease:
E10.90
Medication:
Levemir
Parameter:
Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
Gender:
Male
Age:
18 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
83.5 kg
Height:
173 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Autoimmune thyroiditis [E06.3]
  • E10.90
  • vitamin D deficiency
Medication:
  • Levemir
  • Vigantoletten (specific information from donor: Vigantolette 500 IU)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual:
Quant: 230.90 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Anti-Thyroid peroxidase (aTPO / MAK)
Qual:
Quant: 149.60 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 2.98 mIU/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine (FT4)
Qual:
Quant: 9.80 pmol/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triiodothyronine (FT3)
Qual:
Quant: 6.85 pmol/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH167019
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 83 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
ASS
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
83 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
75 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
Medication:
  • ASS
  • Metoprolol
  • Ramipril
  • amlodipine
  • no incretin mimetics
  • no insulin
  • none
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH169795
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Female Age: 72 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Candesartan
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
72 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
84 kg
Height:
168 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • hypertension
  • polyarthritis
Medication:
  • Candesartan
  • amlodipine
  • metfomin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.7 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165508
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 65 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
65 Years
Ethnic group:
European/Caucasian
BMI:
33 kg/m²
Weight:
85 kg
Height:
161 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • asthma
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Blood glucose (postprandial)
Qual:
Quant: 132.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 5.70 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165494
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9

Donor:
Gender: Female Age: 74 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
incretin mimetics
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
74 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
68.8 kg
Height:
155 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • hypothyroidism
Medication:
  • incretin mimetics
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Blood sugar (fasting)
Qual:
Quant: 78.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165492
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 79 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Bisoprolol
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
79 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
75 kg
Height:
153 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • gastritis
  • hyperlipoproteinaemia
  • hypertension
Medication:
  • Bisoprolol
  • Ramipril
  • Xarelto
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284063
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9

Donor:
Gender: Female Age: 50 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Metex
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
50 Years
Ethnic group:
European/Caucasian
BMI:
31 kg/m²
Weight:
90 kg
Height:
170 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • rheumatism - 1 (not specified)
  • thyroid disease - 1 (not specified)
Medication:
  • Metex
  • Novorapid
  • Protaphan
  • insulin
  • metformin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165636
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E78.2

Donor:
Gender: Female Age: 41 Ethnic group: Not specified
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Prednisolon
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
41 Years
Ethnic group:
Not specified
BMI:
32 kg/m²
Weight:
84 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Mixed hyperlipidaemia [E78.2]
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Prednisolon (specific information from donor: Prednisolon 5 mg)
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 173 mg/dl
Source: this donation
Method: not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165459
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 72 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Nebivolol
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
72 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
80 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90]
  • hyperlipoproteinaemia
  • hypertension
Medication:
  • Nebivolol
  • amlodipine
  • metfomin
  • no incretin mimetics
  • no insulin
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284062
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
L-thyroxine
Parameter:
Hepatitis B Virus surface Antigen (HBsAg) Hepatitis C Virus ribonucleic acid (HCV-RNA) Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
18 kg/m²
Weight:
52 kg
Height:
160 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.90
  • atrial fibrillation
Medication:
  • L-thyroxine (specific information from donor: L-thyroxine 100)
  • metformin
  • no insulin
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis C Virus ribonucleic acid (HCV-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: qPCR (Real-Time Quantitative PCR)
System: Cobas Ampliprep/Cobas TaqMan Roche
Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: PCR (Polymerase Chain Reaction)
System: Cobas Ampliprep/Cobas TaqMan Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165346
1 mL (€75.00)
Will be delivered in 16 to 20 Business Days (€180.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - E11.90

Donor:
Gender: Female Age: 72 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Dekristol
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
72 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
67 kg
Height:
150 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • E11.90
Medication:
  • Dekristol (Dosages: 20000/week, acitve agent: vitamin D3)
  • hydroxychloroquine (Dosages: 400/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 0.90 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.68 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 75.00 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: positive
Quant: 62.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total IgM
Qual: negative
Quant: 83.00 mg/dl
Source: this donation
40.00 - 230.00 mg/dl
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 54.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295181
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 69 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
69 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
83 kg
Height:
172 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • metformin
  • no incretin mimetics
  • no insulin
Therapy:
  • implant
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH166126
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9

Donor:
Gender: Male Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Lantus
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
71 kg
Height:
172 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Lantus
  • atorvastatin (specific information from donor: atorvastatin 20)
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose
Qual: negative
Quant: < 6.5 %
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165577
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.9

Donor:
Gender: Male Age: 80 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Actrapid
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
80 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
98 kg
Height:
187 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Actrapid
  • Toujeo
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284126
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9

Donor:
Gender: Male Age: 49 Ethnic group: Asian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
L-thyroxine
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
49 Years
Ethnic group:
Asian
BMI:
26 kg/m²
Weight:
99 kg
Height:
196 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • L-thyroxine
  • Victoza
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.20 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165485
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 60 Ethnic group: Not specified
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
60 Years
Ethnic group:
Not specified
BMI:
30 kg/m²
Weight:
79 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 107.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165575
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Female Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
no incretin mimetics
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
78 kg
Height:
164 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Anamneses:
  • dietary change diet (information given at the time of donation)
Diseases:
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • no incretin mimetics
  • no insulin
Therapy:
  • gastric bypass
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.90 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH198043
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - E11.21

Donor:
Gender: Female Age: 76 Ethnic group: Not specified
Diagnosed disease:
E11.21
Medication:
Januvia
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
76 Years
Ethnic group:
Not specified
BMI:
27 kg/m²
Weight:
68 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.21]
Medication:
  • Januvia (specific information from donor: Januvia 50 mg)
  • Losartan (specific information from donor: Losartan 100 mg)
  • Prednisolon (specific information from donor: Prednisolon 1 mg)
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165523
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Lantus
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
71.5 kg
Height:
138 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Lantus
  • Liprolog
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 149.00 mg/dl
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.20 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH170850
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 59 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
Novorapid
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
59 Years
Ethnic group:
European/Caucasian
BMI:
35 kg/m²
Weight:
117 kg
Height:
184 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • Novorapid
  • Toujeo
  • Trulicity
  • insulin
  • metformin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.6 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283499
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - D35.2

Donor:
Gender: Male Age: 59 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
59 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
103 kg
Height:
180 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Benign neoplasm of pituitary gland [D35.2]
  • I10.90
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
  • hypertension
  • pituitary adenoma
Medication:
  • insulin
  • metformin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283998
1 mL (€37.50)
Will be delivered in 16 to 20 Business Days (€180.00)